Merck & Co., Inc.
Top Portfolio Positions
9 positions ·
$315,241,752 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| MRNA |
Moderna, Inc.
Healthcare
|
2,308,190 | $117,256,052 | 37.20% | |
| PSNL |
Personalis, Inc.
Healthcare
|
14,044,943 | $89,466,286 | 28.38% | |
| KYMR |
Kymera Therapeutics, Inc.
Healthcare
|
772,165 | $64,313,622 | 20.40% | |
| EIKN |
Eikon Therapeutics, Inc.
Healthcare
|
1,666,666 | $17,633,326 | 5.59% | |
| AKTS |
Aktis Oncology, Inc.
Healthcare
|
952,844 | $17,046,379 | 5.41% | |
| ALEC |
Alector, Inc.
Healthcare
|
3,545,719 | $7,623,295 | 2.42% | |
| VRDN |
Viridian Therapeutics, Inc.DE
Healthcare
|
93,414 | $1,827,177 | 0.58% | |
| NEUP |
Neuphoria Therapeutics Inc.
Healthcare
|
10,027 | $40,809 | 0.01% | |
| HURA |
TuHURA Biosciences, Inc./NV
Healthcare
|
19,445 | $34,806 | 0.01% |
Portfolio Trend
6 quarters · across all stocks
Holdings in KYMR
Shares Held
Position Value (USD)
6 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $64,313,622 | 772,165 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $60,082,158 | 772,165 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $43,704,539 | 772,165 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $33,697,280 | 772,165 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $21,134,156 | 772,165 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $31,064,197 | 772,165 | Shares | Defined | 2025-02-14 | |
| No 13F history on record for this holder in this stock. | ||||||